|MDACC Study No:||RTOG0834 (clinicaltrials.gov NCT No: NCT00626990)|
|Title:||Phase III trial on Concurrent and Adjuvant Temozolomide chemotherapy in non - 1p/19q deleted anaplastic glioma. The CATNON Intergroup trial.|
|Principal Investigator:||John DeGroot|
|Study Description:||The goal of the screening consent is to learn if you are eligible to take part |
in the main research study. The goal of the clinical research study is to learn
if giving temozolomide in combination with radiation therapy can help to
control anaplastic glioma for a longer time than standard radiation therapy
alone. The safety of this combination treatment will also be studied.